Logo image of CHR.CA

CHORUS AVIATION INC (CHR.CA) Stock Fundamental Analysis

Canada - Toronto Stock Exchange - TSX:CHR - CA17040T8885 - Common Stock

21.44 CAD
+0.19 (+0.89%)
Last: 11/25/2025, 7:00:00 PM
Fundamental Rating

4

CHR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 7 industry peers in the Passenger Airlines industry. CHR has an average financial health and profitability rating. CHR has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CHR was profitable.
CHR had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CHR reported negative net income in multiple years.
CHR had a positive operating cash flow in each of the past 5 years.
CHR.CA Yearly Net Income VS EBIT VS OCF VS FCFCHR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

The Return On Assets of CHR (-2.62%) is comparable to the rest of the industry.
The Return On Equity of CHR (-6.31%) is better than 71.43% of its industry peers.
CHR's Return On Invested Capital of 6.40% is amongst the best of the industry. CHR outperforms 100.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CHR is in line with the industry average of 5.26%.
The 3 year average ROIC (5.30%) for CHR is below the current ROIC(6.40%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -2.62%
ROE -6.31%
ROIC 6.4%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
CHR.CA Yearly ROA, ROE, ROICCHR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

1.3 Margins

Looking at the Operating Margin, with a value of 6.81%, CHR is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
CHR's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 65.68%, CHR belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of CHR has declined.
Industry RankSector Rank
OM 6.81%
PM (TTM) N/A
GM 65.68%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
CHR.CA Yearly Profit, Operating, Gross MarginsCHR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CHR is destroying value.
CHR has less shares outstanding than it did 1 year ago.
CHR has more shares outstanding than it did 5 years ago.
CHR has a better debt/assets ratio than last year.
CHR.CA Yearly Shares OutstandingCHR.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CHR.CA Yearly Total Debt VS Total AssetsCHR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

CHR has an Altman-Z score of 0.93. This is a bad value and indicates that CHR is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CHR (0.93) is comparable to the rest of the industry.
CHR has a debt to FCF ratio of 10.63. This is a negative value and a sign of low solvency as CHR would need 10.63 years to pay back of all of its debts.
The Debt to FCF ratio of CHR (10.63) is better than 100.00% of its industry peers.
A Debt/Equity ratio of 0.50 indicates that CHR is somewhat dependend on debt financing.
CHR's Debt to Equity ratio of 0.50 is amongst the best of the industry. CHR outperforms 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 10.63
Altman-Z 0.93
ROIC/WACC0.78
WACC8.24%
CHR.CA Yearly LT Debt VS Equity VS FCFCHR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.22 indicates that CHR should not have too much problems paying its short term obligations.
CHR has a Current ratio of 1.22. This is comparable to the rest of the industry: CHR outperforms 57.14% of its industry peers.
A Quick Ratio of 0.63 indicates that CHR may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.63, CHR is in line with its industry, outperforming 42.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 0.63
CHR.CA Yearly Current Assets VS Current LiabilitesCHR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

3

3. Growth

3.1 Past

CHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 92.86%, which is quite impressive.
Measured over the past years, CHR shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -19.03% on average per year.
The Revenue has decreased by -8.40% in the past year.
Measured over the past years, CHR shows a small growth in Revenue. The Revenue has been growing by 0.56% on average per year.
EPS 1Y (TTM)92.86%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%42.86%
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-5.39%

3.2 Future

Based on estimates for the next years, CHR will show a small growth in Earnings Per Share. The EPS will grow by 6.05% on average per year.
The Revenue is expected to decrease by -4.27% on average over the next years.
EPS Next Y55.58%
EPS Next 2Y13.32%
EPS Next 3Y6.05%
EPS Next 5YN/A
Revenue Next Year-4.85%
Revenue Next 2Y-3.78%
Revenue Next 3Y-4.27%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CHR.CA Yearly Revenue VS EstimatesCHR.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CHR.CA Yearly EPS VS EstimatesCHR.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 8.82 indicates a reasonable valuation of CHR.
Compared to the rest of the industry, the Price/Earnings ratio of CHR indicates a rather cheap valuation: CHR is cheaper than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.98, CHR is valued rather cheaply.
A Price/Forward Earnings ratio of 11.06 indicates a reasonable valuation of CHR.
Based on the Price/Forward Earnings ratio, CHR is valued cheaper than 85.71% of the companies in the same industry.
CHR is valuated cheaply when we compare the Price/Forward Earnings ratio to 35.79, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.82
Fwd PE 11.06
CHR.CA Price Earnings VS Forward Price EarningsCHR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CHR is valued a bit cheaper than 71.43% of the companies in the same industry.
CHR's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CHR is cheaper than 71.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.81
EV/EBITDA 4.08
CHR.CA Per share dataCHR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.16
PEG (5Y)N/A
EPS Next 2Y13.32%
EPS Next 3Y6.05%

3

5. Dividend

5.1 Amount

CHR has a Yearly Dividend Yield of 1.48%.
Compared to an average industry Dividend Yield of 2.53, CHR has a dividend in line with its industry peers.
CHR's Dividend Yield is slightly below the S&P500 average, which is at 2.41.
Industry RankSector Rank
Dividend Yield 1.48%

5.2 History

The dividend of CHR is nicely growing with an annual growth rate of 21.58%!
CHR has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)21.58%
Div Incr Years0
Div Non Decr Years0
CHR.CA Yearly Dividends per shareCHR.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2025 1 2 3

5.3 Sustainability

The earnings of CHR are negative and hence is the payout ratio. CHR will probably not be able to sustain this dividend level.
CHR's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP-5.89%
EPS Next 2Y13.32%
EPS Next 3Y6.05%
CHR.CA Yearly Income VS Free CF VS DividendCHR.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

CHORUS AVIATION INC

TSX:CHR (11/25/2025, 7:00:00 PM)

21.44

+0.19 (+0.89%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)02-11 2026-02-11/amc
Inst Owners3.2%
Inst Owner ChangeN/A
Ins Owners1.35%
Ins Owner ChangeN/A
Market Cap546.29M
Revenue(TTM)1.35B
Net Income(TTM)-34.96M
Analysts78
Price Target30.26 (41.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.48%
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-5.89%
Div Incr Years0
Div Non Decr Years0
Ex-Date12-12 2025-12-12 (0.08)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.44%
Min EPS beat(2)3.86%
Max EPS beat(2)11.03%
EPS beat(4)4
Avg EPS beat(4)11.06%
Min EPS beat(4)3.86%
Max EPS beat(4)25.51%
EPS beat(8)6
Avg EPS beat(8)17.12%
EPS beat(12)6
Avg EPS beat(12)4.64%
EPS beat(16)8
Avg EPS beat(16)3.17%
Revenue beat(2)0
Avg Revenue beat(2)-6.2%
Min Revenue beat(2)-8.31%
Max Revenue beat(2)-4.09%
Revenue beat(4)0
Avg Revenue beat(4)-5.03%
Min Revenue beat(4)-8.31%
Max Revenue beat(4)-3.78%
Revenue beat(8)2
Avg Revenue beat(8)-4.05%
Revenue beat(12)5
Avg Revenue beat(12)-1.79%
Revenue beat(16)7
Avg Revenue beat(16)0.32%
PT rev (1m)5.79%
PT rev (3m)5.79%
EPS NQ rev (1m)7.14%
EPS NQ rev (3m)5%
EPS NY rev (1m)0.17%
EPS NY rev (3m)0.17%
Revenue NQ rev (1m)-0.69%
Revenue NQ rev (3m)-1.32%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 8.82
Fwd PE 11.06
P/S 0.4
P/FCF 16.81
P/OCF 7.67
P/B 0.99
P/tB 1
EV/EBITDA 4.08
EPS(TTM)2.43
EY11.33%
EPS(NY)1.94
Fwd EY9.04%
FCF(TTM)1.28
FCFY5.95%
OCF(TTM)2.79
OCFY13.03%
SpS52.96
BVpS21.76
TBVpS21.41
PEG (NY)0.16
PEG (5Y)N/A
Graham Number34.49
Profitability
Industry RankSector Rank
ROA -2.62%
ROE -6.31%
ROCE 8.63%
ROIC 6.4%
ROICexc 6.56%
ROICexgc 6.62%
OM 6.81%
PM (TTM) N/A
GM 65.68%
FCFM 2.41%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexgc growth 3Y33.52%
ROICexgc growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score6
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 10.63
Debt/EBITDA 1.32
Cap/Depr 32.58%
Cap/Sales 2.87%
Interest Coverage 2.74
Cash Conversion 33.79%
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 0.63
Altman-Z 0.93
F-Score6
WACC8.24%
ROIC/WACC0.78
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)92.86%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%42.86%
EPS Next Y55.58%
EPS Next 2Y13.32%
EPS Next 3Y6.05%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-5.39%
Revenue Next Year-4.85%
Revenue Next 2Y-3.78%
Revenue Next 3Y-4.27%
Revenue Next 5YN/A
EBIT growth 1Y-34.45%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year86.18%
EBIT Next 3Y12.53%
EBIT Next 5YN/A
FCF growth 1Y-89.3%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-80.17%
OCF growth 3Y12.73%
OCF growth 5Y0.25%

CHORUS AVIATION INC / CHR.CA FAQ

What is the fundamental rating for CHR stock?

ChartMill assigns a fundamental rating of 4 / 10 to CHR.CA.


What is the valuation status for CHR stock?

ChartMill assigns a valuation rating of 7 / 10 to CHORUS AVIATION INC (CHR.CA). This can be considered as Undervalued.


Can you provide the profitability details for CHORUS AVIATION INC?

CHORUS AVIATION INC (CHR.CA) has a profitability rating of 5 / 10.


What are the PE and PB ratios of CHORUS AVIATION INC (CHR.CA) stock?

The Price/Earnings (PE) ratio for CHORUS AVIATION INC (CHR.CA) is 8.82 and the Price/Book (PB) ratio is 0.99.


What is the expected EPS growth for CHORUS AVIATION INC (CHR.CA) stock?

The Earnings per Share (EPS) of CHORUS AVIATION INC (CHR.CA) is expected to grow by 55.58% in the next year.